| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/13/2011 | US20110008262 Drug delivery system targeting to estrogen receptor over-expressed cells |
| 01/13/2011 | US20110008250 Treatment of Autoimmune Diseases |
| 01/13/2011 | CA2803282A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | CA2767692A1 Pharmaceutical composition for a hepatitis c viral protease inhibitor |
| 01/13/2011 | CA2767600A1 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions |
| 01/13/2011 | CA2767493A1 Peracid/peroxide composition, process for accurately making the same, and method for use as an evaporating film anti-microbial solution and as a photosensitizer |
| 01/13/2011 | CA2767460A1 Liquid pharmaceutical form of alkylphosphocholine and method of preparing same |
| 01/13/2011 | CA2767459A1 Ethyleneoxide butyleneoxide block copolymer compositions |
| 01/13/2011 | CA2767443A1 Biopolymer hybrid gel-depot delivery system |
| 01/13/2011 | CA2767440A1 Pharmaceutical compositions and solid forms |
| 01/13/2011 | CA2767342A1 Matrix carrier compositions, methods and uses |
| 01/13/2011 | CA2767260A1 Solid linear oligo-or poly-.epsilon.-caprolactone derivatives |
| 01/13/2011 | CA2767251A1 Insulin preparations containing methionine |
| 01/13/2011 | CA2767149A1 Pegylated l-asparaginase |
| 01/13/2011 | CA2767143A1 Tablet having hollow structure |
| 01/13/2011 | CA2766634A1 Methods and compositions using peptides and proteins with c-terminal elements |
| 01/13/2011 | CA2766608A1 Bi-specific digoxigenin binding antibodies |
| 01/13/2011 | CA2765090A1 A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 01/13/2011 | CA2764792A1 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition |
| 01/13/2011 | CA2762524A1 Carbon nanotubes complexed with multiple bioactive agents and methods related thereto |
| 01/12/2011 | EP2272947A1 Peptide conjugated anti-cancer prodrugs |
| 01/12/2011 | EP2272875A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 01/12/2011 | EP2272869A2 Angiopoietin-2 specific binding agents |
| 01/12/2011 | EP2272865A2 Method of producing hydroxyalkyl starch derivatives |
| 01/12/2011 | EP2272864A2 Binding agents which inhibit myostatin |
| 01/12/2011 | EP2272861A1 Polyepitope carrier protein |
| 01/12/2011 | EP2272537A2 Salts of conjugated psychotropic drugs and processes of preparing same |
| 01/12/2011 | EP2272536A2 Hot-melt extrudable Pharmaceutical formulation |
| 01/12/2011 | EP2272531A2 Integration of meningococcal conjugate vaccination |
| 01/12/2011 | EP2272530A2 Antigenic Compositions |
| 01/12/2011 | EP2272508A2 Pharmaceutical Formulations for Dry Powder Inhalers |
| 01/12/2011 | EP2272506A2 Microcapsules with modified release of low-solubility active ingredients for oral administration |
| 01/12/2011 | EP2272503A2 Oral formulations of cladribine |
| 01/12/2011 | EP2272501A1 Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate |
| 01/12/2011 | EP2272488A1 Vesicle and cosmetic containing the same |
| 01/12/2011 | EP2271699A1 Biodegradable cross-linked branched poly (alkylene imines) |
| 01/12/2011 | EP2271368A1 Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery |
| 01/12/2011 | EP2271359A2 Camptothecin-binding moiety conjugates |
| 01/12/2011 | EP2271352A1 Compositions and methods for treatment of neoplastic disease |
| 01/12/2011 | EP2271349A1 Compositions and methods for skin care |
| 01/12/2011 | EP2271347A2 Administration of benzodiazepine compositions |
| 01/12/2011 | EP2271322A2 Encapsulation of biologically active agents |
| 01/12/2011 | EP2271320A1 Raloxifene pharmaceutical formulations |
| 01/12/2011 | EP2271319A1 Formulation with reduced hygroscopicity |
| 01/12/2011 | EP2271314A2 Compositions and methods for the preparation of nanoemulsions |
| 01/12/2011 | EP2271313A1 Phosphate buffered ophthalmic solutions displaying improved efficacy |
| 01/12/2011 | EP2271312A2 Nerve repair with a hydrogel and optional adhesive |
| 01/12/2011 | EP2271214A2 Pharmaceutical solutions and method for solubilizing therapeutic agents |
| 01/12/2011 | EP2271211A2 A topical ectoparasiticide composition |
| 01/12/2011 | EP2271204A2 Dog pheromone formulation and delivery system |
| 01/12/2011 | EP2094308B1 Stable parenteral formulation containing a rsv inhibitor of a benzodiazepine structure |
| 01/12/2011 | EP1991586B1 Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents |
| 01/12/2011 | EP1938808B1 Preparation for external use comprising tamsulosin |
| 01/12/2011 | EP1814523B9 Solid, oral drug form which has been designed to prevent misuse |
| 01/12/2011 | EP1778289B1 Carrier for enteral administration |
| 01/12/2011 | EP1523287B1 Materials with both bioadhesive and biodegradable components |
| 01/12/2011 | CN1985994B Improved enteric medicine composition with mycophenolate |
| 01/12/2011 | CN1823771B FK506 oral medicinal composition |
| 01/12/2011 | CN1675245B Monoclonal antibody hPAM4 |
| 01/12/2011 | CN1668314B Methods of treating hepatitis |
| 01/12/2011 | CN101946001A Polypeptide-nucleic acid conjugates and uses thereof |
| 01/12/2011 | CN101945924A Fine powder of polyamide from renewable materials and method for making such powder |
| 01/12/2011 | CN101945892A Methods and agents for improving targeting of cd138 expressing tumor cells |
| 01/12/2011 | CN101945671A Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 01/12/2011 | CN101945670A Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 01/12/2011 | CN101945669A Large particle size crystallised maltitol powder, method for preparing same and applications thereof, particularly in chocolate production |
| 01/12/2011 | CN101945657A Tablet having improved elution properties |
| 01/12/2011 | CN101945654A Alpha-lipoic acid nanoparticle and method for producing the same |
| 01/12/2011 | CN101942445A Nucleic acid aptamer derivative and application thereof in preparation of medicament carrier |
| 01/12/2011 | CN101942198A Preparation method of porous silicon hydrogel interpenetrating network (IPN) membrane |
| 01/12/2011 | CN101942101A Preparation method of amphiphilic polyelectrolyte graft containing hydrophobic alkyl side chains |
| 01/12/2011 | CN101942097A Method for preparing glycosyl amide modified polysiloxane |
| 01/12/2011 | CN101942079A Method for catalytically synthesizing polylactic acid by using calcined kaolin as catalyst |
| 01/12/2011 | CN101942026A Long-acting interferon fusion protein and application thereof |
| 01/12/2011 | CN101942023A Human epidermic growth factor ferritin heavy chain subunit fusion protein, constructing method and use thereof |
| 01/12/2011 | CN101942022A Anti-human epidermal growth factor receptor single-chain antibody-ferritin heavy chain subunit protein and construction method and application thereof |
| 01/12/2011 | CN101941077A Method for preparing magnetic metal iron-encapsulated fullerene carbon spheres |
| 01/12/2011 | CN101940793A Hydroxypropyl-beta-cyclodextrin clathrate compound of cantharidin and cantharis extractive and preparation method thereof |
| 01/12/2011 | CN101940792A PCL-b-PEG-b-PCL carried hydrophobic medicine polymer vesica as well as preparation method and application thereof |
| 01/12/2011 | CN101940791A Dually-targeted pH-sensitive antineoplastic drug carrier material as well as preparation and application thereof |
| 01/12/2011 | CN101940790A Novel penetration-promoting agent composition and application thereof to transdermal administration system |
| 01/12/2011 | CN101940785A Hydrogen sulfide-producing enzyme preparation and use thereof |
| 01/12/2011 | CN101940782A Lanreotide long-acting injection microsphere preparation and preparation method thereof |
| 01/12/2011 | CN101940745A Jinji blood stasis eliminating particles and preparation method thereof |
| 01/12/2011 | CN101940695A Chinese medicinal ointment for treating vitiligo and preparation method thereof |
| 01/12/2011 | CN101940640A Method for preparing medicinal composition for treating coronary heart disease |
| 01/12/2011 | CN101940619A Chinese medicinal preparation for treating guillain-barre syndrome (GBS) diseases and preparation method thereof |
| 01/12/2011 | CN101940607A Effervescent composition including cranberry extract |
| 01/12/2011 | CN101940602A Pediatric compound chicken's gizzard-membrane chewable tablets and preparation method thereof |
| 01/12/2011 | CN101940575A Cefditoren pivoxil solid preparation and preparation method thereof |
| 01/12/2011 | CN101940567A Fish medicament for treating vitamin C and vitamin E deficiency diseases |
| 01/12/2011 | CN101940564A Water-soluble coenzyme Q10 combination and preparation method thereof |
| 01/12/2011 | CN101940563A Ornidazole mouth mucosa slow-release patch and preparation method thereof |
| 01/12/2011 | CN101940562A Solid preparation of febuxostat or medicinal salt thereof and preparation method thereof |
| 01/12/2011 | CN101940561A Quetiapine fumarate tablet and preparation method thereof |
| 01/12/2011 | CN101940560A Minocycline hydrochloride sustained-release tablets and method for preparing same with different specifications |
| 01/12/2011 | CN101940557A Method for preparing fat-soluble vitamin freeze-dried powder injection |
| 01/12/2011 | CN101940556A Preparation method of diammonium glycyrrhizinate freeze-dried powder injection |
| 01/12/2011 | CN101940555A Method for preparing azithromycin freeze-dried powder injection for injection |
| 01/12/2011 | CN101940554A Multi-core adhesive microspheres for loading water soluble low molecular medicament and preparation method thereof |